DURECT Corporation (DRRX)
Sep 11, 2025 - DRRX was delisted (reason: acquired by BHC)
1.910
-0.020 (-1.04%)
Inactive · Last trade price on Sep 10, 2025
DURECT Revenue
DURECT had revenue of $447.00K in the quarter ending June 30, 2025, a decrease of -30.80%. This brings the company's revenue in the last twelve months to $1.66M, down -511.17% year-over-year. In the year 2024, DURECT had annual revenue of $2.03M, down -21.58%.
Revenue (ttm)
$1.66M
Revenue Growth
-511.17%
P/S Ratio
35.78
Revenue / Employee
$78,905
Employees
21
Market Cap
59.31M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.03M | -559.00K | -21.58% |
Dec 31, 2023 | 2.59M | -16.69M | -86.57% |
Dec 31, 2022 | 19.28M | 5.31M | 37.96% |
Dec 31, 2021 | 13.98M | -16.13M | -53.58% |
Dec 31, 2020 | 30.11M | 5.04M | 20.09% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionDRRX News
- 20 days ago - Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025 - Accesswire
- 4 weeks ago - DURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch Health - PRNewsWire
- 6 weeks ago - Bausch Health Adds Late-Stage Ready Alcohol Liver Disease Drug Candidate In $63 Million DURECT Buyout - Benzinga
- 6 weeks ago - Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease - Accesswire
- 4 months ago - DURECT Corporation Reports First Quarter 2025 Financial Results and Provides Business Update - PRNewsWire
- 6 months ago - DURECT Corporation (DRRX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - DURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - PRNewsWire
- 6 months ago - DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update - PRNewsWire